Safety/efficacy trial using stored serum samples to investigate the immunogenicity of insulin aspart and soluble human insulin in children and adolescents from onset of type 1 diabetes
Phase of Trial: Phase III
Latest Information Update: 24 Dec 2016
At a glance
- Drugs Insulin aspart (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 15 Jun 2012 Actual patient number is 74 as reported by ClinicalTrials.gov.
- 15 Jun 2012 Actual end date (1 May 2006) added as reported by ClinicalTrials.gov.